J&J Settles With Novartis

Novartis's CIBA Vision division has reached a global settlement with Johnson & Johnson Vision Care to license CIBA's ?Nicholson' patents for silicone hydrogel contact lens technology. The terms of the agreement are confidential. The settlement ends ongoing litigation in the U.S. as well as several European countries.

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.